Kidney Transplantation Can Improve Quality of Life for ESRD Patients
Hosted by the Hamilton Chapter of the Polycystic Kidney Disease (PKD) Foundation of Canada, Dr. Russell, MD, FCRP, will review the historical development of transplantation, how it works, and the benefits in terms of quality of life and longevity.
Hamilton, Canada, November 14, 2011 --(PR.com)-- A talk about kidney transplantation by McMaster University nephrology expert Dr. David Russell on November 19 promises to be informative and encouraging.
Dr. Russell MD, FCRP, will examine the roles of both dialysis and transplantation in the management of patients who develop end-stage kidney failure (also known as end-stage renal disease or ESRD).
He will also discuss the need for lifelong anti-rejection drug therapy and its complications.
Lastly, he will outline some of the ethical issues involved in transplantation, how waiting lists work and how fairness is built into the system.
"I have clinical interests in both kidney transplantation and cardiac disease in patients with chronic kidney disease, as well as research interests in non-invasive cardiac testing for wait-listed transplant patients," Dr. Russell said.
Dr. Russell is Chief of Medicine with St. Joseph's Healthcare; Director, Renal Transplant Program; and Associate Professor at McMaster University, in the Nephrology Division, Department of Medicine.
Following the talk, a representative of the Trillium Gift of Life Network will be available to answer questions about organ donation.
This two-hour informational meeting takes place at 170 Dundurn Street South in Hamilton, from 2 p.m. on November 19, 2011. More information is available by contacting hamiltonchapter@endpkd.ca or calling 1-800-410-1741.
Polycystic Kidney Disease (PKD) affects approximately 1 in 500 people. The PKD Foundation of Canada supports research towards a cure for this genetic and often fatal disease.
###
Dr. Russell MD, FCRP, will examine the roles of both dialysis and transplantation in the management of patients who develop end-stage kidney failure (also known as end-stage renal disease or ESRD).
He will also discuss the need for lifelong anti-rejection drug therapy and its complications.
Lastly, he will outline some of the ethical issues involved in transplantation, how waiting lists work and how fairness is built into the system.
"I have clinical interests in both kidney transplantation and cardiac disease in patients with chronic kidney disease, as well as research interests in non-invasive cardiac testing for wait-listed transplant patients," Dr. Russell said.
Dr. Russell is Chief of Medicine with St. Joseph's Healthcare; Director, Renal Transplant Program; and Associate Professor at McMaster University, in the Nephrology Division, Department of Medicine.
Following the talk, a representative of the Trillium Gift of Life Network will be available to answer questions about organ donation.
This two-hour informational meeting takes place at 170 Dundurn Street South in Hamilton, from 2 p.m. on November 19, 2011. More information is available by contacting hamiltonchapter@endpkd.ca or calling 1-800-410-1741.
Polycystic Kidney Disease (PKD) affects approximately 1 in 500 people. The PKD Foundation of Canada supports research towards a cure for this genetic and often fatal disease.
###
Contact
PKD Foundation of Canada - Hamilton Chapter
Shiona Mackenzie-Morrison, Hamilton Chapter Coordinator
1-877-410-1741
www.endpkd.ca/index.asp
J. Robertson
T: +1 416-516-8591
E: endpkd@endpkd.ca
Shiona Mackenzie-Morrison, Hamilton Chapter Coordinator
1-877-410-1741
www.endpkd.ca/index.asp
J. Robertson
T: +1 416-516-8591
E: endpkd@endpkd.ca
Contact
Categories